The Ghana Food and Drugs Authority (FDA) has spearheaded a joint initiative with National Regulatory Authorities (NRAs) in seven African countries to foster trust, enhance regulatory reliance, and streamline approval processes for medicines, vaccines, and medical devices.
This initiative, established through a Memorandum of Understanding (MoU), signed between Ghana and six other Africa countries aimed to significantly reduce approval timelines and improve access to essential medical products through internationally recognized best practices.
The other participating NRAs are from South Africa, Nigeria, Rwanda, Tanzania, Zimbabwe, and Senegal.
The landmark MoU was signed in Cairo on February 4, under the auspices of the African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) and the Africa Centres for Disease Control and Prevention (Africa CDC).
